To obtain detailed profiling of the B-ALL-associated microenvironment, original BM samples were separated into CD19+ B cell and CD19−CD45+ non-B cell proportions and mixed at a ratio of 1:5 [39]. Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.